Dr. David Hakimian
Claim this profileGSK Investigational Site
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
5 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials David Hakimian is currently running
More about David Hakimian
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments David Hakimian has experience with
- Niraparib
- Pembrolizumab
- Placebo
- Docetaxel
- SGN-B6A
Breakdown of trials David Hakimian has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hakimian specialize in?
David Hakimian focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is David Hakimian currently recruiting for clinical trials?
Yes, David Hakimian is currently recruiting for 1 clinical trial in Niles Illinois. If you're interested in participating, you should apply.
Are there any treatments that David Hakimian has studied deeply?
Yes, David Hakimian has studied treatments such as Niraparib, Pembrolizumab, Placebo.
What is the best way to schedule an appointment with David Hakimian?
Apply for one of the trials that David Hakimian is conducting.
What is the office address of David Hakimian?
The office of David Hakimian is located at: GSK Investigational Site, Niles, Illinois 60714 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.